This is a preview of subscription content, log in via an institution.
Preview
Unable to display preview. Download preview PDF.
Literatur
Ablad B, Börjessen E, Carlsson E, Johnsson G (1975) Effects of metoprolol and propranolol on some metabolic responses to catecholamines in the anesthetized dogs. Acta Pharmocol et Toxicol 36, Suppl V, 85
Ääiynen M, Mäkelä M, Hämeenaho P, Mattila MJ (1981) Prazosin enhances the antihypertensive effects of beta-blockers during isometric and dynamic exercise. Am Clin Research 132: 71
Ahlborg G, Feiig P, Hagenfeldt L, Hendler R, Wahren J (1974) Substrate turnover during prolonged exercise in man: splanchnic and leg metabolism of glucose, free fatty acids and amino acids. J Clin Invest 53: 1080
Ahlborg G, Felig P (1976) Influence of glucose ingestion on fuel-hormone response during prolonged exercise. J Appl Physiol 41: 683
Ahlborg G and Felig P (1977) Substrate utilization during prolonged exercise preceded by ingestion of glucose. Am J Physiol 233 (Endocrinol Metab Gastrointest Physiol 2): El 88
Ahlborg G, Felig P (1982) Lactate and glucose exchange across the forearm, legs and splanchnic bed during and after prolonged leg exercise. J Clin Invest 65: 45
Ahlquist RP (1967) Development of the concept of alpha and beta adrenotopic receptors. Am NY Acad Sci 139: 549
Aigner A, Muß N, Krempler F, Fenninger H, Sandhofer F (1983) Der Einfluß einer akuten ßr und Rezeptorenblockade auf den Kohlenhydrat- und Fettstoffwechsel unter Belastungsbedingungen. Dtsch Med Wschrl 58: 293
Ambrosioni F, Borghi C, Costa FU, Magnani B (1982) Cardiovascular effects induced in hypertensive patients by prizidilol during stress and exercise. Abstract Ninth Scientific meeting of the International Society of Hypertension. Mexico City, p 15
Ames RP, Hill P (1976) Increase in serum lipids during treatment of hypertension with chlortalidone. Lancet 1: 721
Anavekar SN, Louis WJ, Morgan TQ, Doyle AE, Johnston CI (1975) The relationship of plasma levels of pindolol in hypertensive patients to effects on blood pressure, plasma renin and plasma noradrenaline levels. Clin Exp Pharmacol Physiol 2: 203
Andersen M, Bechsgaard P, Fredriksen J, Hansen D, Jessen-Jürgensen H, Nielsen P, Pedersen F, Pedersen-Bjergaard O, Lind-Rasmussen S (1975) The effect of alprenolol on mortality among patients with definitive or suspected acute myocardial infarction. Lancet 2: 865
Anderson SD, Bye PTP, Perry CP, Hamor GP, Theobald G and Nyberg G (1979) Limitation of work performance in normal adult males in the presence of beta-adrenergic blockade. Aust NZ J Med 9: 515
Anschütz F (1970) Über die Zuverlässigkeit der auskultatorisch ermittelten Blutdruckwerte unter körperlicher Belastung. Fortschr Med 88: 1391
Anderson K, Vik-Mo H (1982) Role of Frank-Starling mechanism during maximal semisupine exercise after oral atenolol. Br Heart J 48: 149
Antonis A, Clark ML, Hodge RL, Molony M, Pilkington TR (1967) Receptor mechanismus in the hyperglycaemic response to adrenaline in man. Lancet 27: 1135
Aoki K, Kondo S, Mochizuki A et al (1978) Antihypertensive effect of cardiovascular Ca22 +2-antagonist in hypertensive patients in the absence and presence of beta-adrenergic blockade. Am Heart J 96: 218–226
Arnold A, McAuliff JP, Colella DF, O’Connor WV and Brown TG (1968) The ft-receptor mediated glycogenolytic responses to catecholamines in the dog. Arch Int Pharmacodyn 176: 451
Ashton WI (1976) An open, multicentre study of acebutolol in hypertension. Curr Med Res Opin 4: 442
Asknes EG (1977) β-Blocker: farlig for skilopere? Tiddskrift for den Norske Laegeforening 12: 576
Astra chemical GmbH (1979) Herzkreislaufinformation 1
Astrand J (1965) Blood pressure during physical work in a group of 221 women and men 48-63 years old. Acta Med Scand 178: 41
Astrand PO, Rodahl K (1977) Textbook of Work Physiology. McGraw-Hill, New York
Atterhög IH, Duner H, Pernow B (1977) Haemodynamic effects of pindolol in hypertensive patients. Acta Med Scand Suppl 606: 55
Bannister EW and Griffiths J (1972) Blood levels of adrenergic amines during exercise. J Appl Physiol 33: 674
Bachmann K (1969) Arbeitsbelastung und Hypertonie. In: Sasse H (Hrsg) Hypertonie, Pathogenese, Klinik und Therapie. Schattauer, Stuttgart New York
Bachmann K, Zerzawy R, Riess PJ, Zölch KA (1970) Blutdrucktelemetrie - kontinuierliche, direkte Blutdruckmessung im Alltag und beim Sport. Dtsch Med Wschr 95: 741
Baller D, Schenk H, Zipfel J, Hellige G (1979) Möglichkeiten und Grenzen von klinischn O2-Verbrauchsparametern. Z Kardiol 68: 656
Barath E (1928) Arterial Hypertension and physical work. Arch Intern Med 42: 296
Barwich D, Klett G, Eckert W, Weicker H (1980) Exercise-induced lipolysis with central Cushing’s disease. Int J Sports Med 1: 120
Bechgaard P (1967) The natural history of benign hypertension - 1000 hypertensive patients followed from 26 to 32 years. In: Stamler J, Stamler R, Pullman TN (eds) The epidemiology of hypertension. Proceedings of an international symposium. Grune and Stratton, New York, p357
Beevers DG, Fairman MJ, Hamilton M, Harpur JE (1973) Antihypertensive treatment and the course of etablished cerebral vascular disease. Lancet 1: 1407
Behrenbeck DW, Tauchert M, Meurer KA, Nieheres B, Jansen W, Hötzel J, Hilger H (1977) Der myokardiale Sauerstoffverbrauch bei Patienten mit arterieller Hypertonie vor und nach Drucksenkung. Verh Dtsch Ges Kreisl Forsch 43: 111
Ben Ari E, Kellermann JJ, Lapitod C, Droiy Y, Fisman E, Hayat M (1978) Effect of prolonged intensive training on cardiorespiratory response in patiente with angina pectoris. Br Heart J40: 1143
Bengtsson E (1956) The working capacity in normal children evaluated by submaximal exercise on the bicycle ergometer compared with adults. Acta Med Scand 154: 91
Berger M, Berchtold P (1979) Beta-Rezeptorenblocker. Dtsch Med Wschr 24: 888
Berglund G, Wilhelmsen L, Sannerstedt R, Hansson L, Anderson O, Sivertsson R, Wikstrand J (1978) Decrease of CHD morbidity by treatment of hypertension. Lancet 1: 1
Berkowitz WD, Wit AL, Lan SH, Steiner C, Damato AN (1969) The effects of propranolol on cardial conduction. Circulation 21: 855
Berry CL (1978) Hypertension and arterial development - Longterm considerations. Br Heart J 40: 709
Bertel O, Kiowski W, Bühler FR (1979) Nieren- und Hochdruckkrankheiten 4: 156
Bethge K-P, Klein H, Lichtlen PR (1979) Koronare Herzerkrankung, Rhythmusstörungen und plötzlicher Herztod. Internistische Welt 4: 107
Beveârd S, Holmgren A, Jonsson (1960) The effect of body position on the circulation at rest and during exercise, with special reference to the influence on the stroke volume. Acta Physiol Scand 49: 279
Bielmann P, Leduc G (1979) Effects of metoprolol and propranolol on lipid metabolism. Int J Clin Pharmacol Biopharm 17: 378
Bielmann P, Leduc G, Germain M, Davignon J (1980) Betablockers and changes in lipoprotein fractions. New Eng J Med 302: 298
Bielmann P, Brun D, Gagné C, Moorjani SC, Jéquier J-C, Berhand M, Lupien P-J (1982) Beta- blockers and their effects on lipoproteins, phospholipids, apoproteins A und B, in whole plasma and the different fraction. Int J Clin pharmacol Ther Tox 20: 259
Birnbaum J, Di Bianco R, Becker KL, Costello RB, Suigh SN, Gottdiener JS, Fletcher RD (1983) Glucose and lipid metabolism during acebutolol and propranolol therapy of angina in nondiabetic patients. Clin Pharmacol Therap 33: 294
Birnbaumer L, Pohl SL, Kaumann AJ (1974) Receptors and aceptors: A necessary distinction in hormone bindung Studies. In: Greengard P, Robinson GA (Hrsg) Advances in cyclic mucleotide research. Vol 4, Raven Press, New York, S 239
Blümchen G, Esche H-H (1981) Belastungshämodynamik des linken Ventrikels unter chronischer Rezeptorenblocker-Therapie bei Herzinfarktpatienten mit geringer Angina-pectoris und guter Belastbarkeit. Z Kardiol 70: 678
Bodem R, Albig M, Barwich D (1978) Kardiale Befunde bei Patienten mit Akromegalie: Eine echokardiographische Studie. Z Kardiol 67: 163
Bodem G, Ochs HR (1979) Pharmakologie der β-Rezeptorenblocker. Dtsch med Wschr 104: 6
Borchard U (1983) Pharmacological properties of diastolol, the major metabolite of acebutolol 3rd International Bayer Beta Blocker Symposium, Rio de Janeiro, Abstracts, p 4
Boyer J, Kasch F (1970) Exercise therapy in hypertensive men. Am J Med Ass 211: 1668
Bradby GVH, Valente AJ, Walton KW (1978) Serum high density lipoproteins in peripheral vascular disease. Lancet II: 1271
Brecht HM, Banthien F, Ernst W, Schoeppe W (1976) Increased plasma noradrenaline concentrations in essential hypertension and their decrease after longterm treatment with a ß-reeeptorblocking agent ( Pindolol ). Clin Sci Mol Med 51: 485
Breckenridge A, Orme M, Dollary CT (1971) The effect of dopamine on renal blood flow in man. Eur J Clin Pharmacol 3: 131
Brest AN (1975) Therapeutic aspects of hypertension. Angiology 26: 584
Brick I, Glover WE, Hutchison KJ and Roddie IC (1966) Effects of propranolol on peripheral vessels in man. Am J Cardiol 18: 329
Brisma K (1981) Prolactin secretion in the empty sella snydrome in prolactinomas and in acromegalic. Acta Med Scand 209: 397
Brown ThG (1968) The ßx-Receptor mediated glycogenolytic responses to catecholamines in the dog. Arch Int Pharmacoclyn 176: 451
Bruce RA, Hossack KF, Kusumi F, Clarke L (1979) Acute effects of oral propranolol on hemodynamic responses to upright exercise. Am J Cardiol 44: 132
Bruhn R, Höffken I, Henry R, Lücker PW (1981) Zur Pharmakodynamik von Acebutolol. Therapiewoche 31: 5470
Buchanan N, Weir RJ (1982) A comparison of nifedipine and mefruside in the treatment of mild/moderate hypertension. Abstract Ninth Scientific Meeting of the International Society of Hypertension. Mexico City, p 59
Bucher HW, Stucki P (1969) The effect of various betareceptor blocking agents on platelet aggregation. Experienta 25: 280
Bühler FR, Bertel O, Kiowski DW (1978) Plasmanoradrenaline and adrenaline and β-adreno- receptor responsiveness in renin subgroups of essential hypertension. Clin Sci Mol Med 55: 57
Bühler FR, Kiowski W, Bolli P, Bertel O (1978) Das Potential der Beta-Blocker in der Hochdruckbehandlung. Internist 19: 510
Burkart F, Bühler FR, Pfisterer M, Küng M (1976) Belastungshämodynamik und Renin vor und nach akuter β-Blockade bei Patienten mit essentieller Hypertonie. Schweiz Med Wschr 106: 1732
Carlson LA, Ekelund L-G, Fröberg SO (1971) Concentration of triglycerides, phospholipids and glycogen in skeletal muscle and of free fatty acids and β-hydroxybutynic acid in blood in man in response to exercise. Eur J Clin Invest 1: 248
Carlsson E, Fellenius E, Lundberg P, Svensson L (1978) β-adrenoceptor blockers, plasma-po tassium and exercise. Lancet 2: 424
Carlström S (1969) Studies on fatty acid metabolism in diabetes during exercise. VII. Plasma glycerol concentrations in juvenile diabetics during exercise before and after adequate insulin treatment. Acta Med Scand 186: 429
Carlström S, Westling H (1970) Metabolic, circulatory and respiratory effects of a new sympathomimetic ß-receptor-stimulating agent, terbutaline, compared with those of orciprenaline. Acta Med Scand Suppl 512: 33
Carvalho AC, Colman RW, Lees RS (1974) Platelet function in hyperlipoproteinaemia. New Engl J Med 290: 434
Castelli WP, Doyle JT, Gordon T, Haines CG, Hjostland MC, Hulley SB, Kagan A, Zukel WJ (1977) HDL-Cholesterol and other lipids in coronary heart disease. Circulation 55: 767
Chodakowska J, Nazar K, Wocial B, Jarecki M, Skorka B (1975) Plasma catecholamines and renin activity in response to exercise in patients with essential hypertension. Clin Sci Mol Med 49: 511
Choquette E, Ferguson R (1973) Blood pressure reduction in boderline hypertensives following physical training. Canad Med Ass J108: 699
Christensen NJ, Brandsborg O (1973) The relationship between plasma catecholamine concentration and pulse rate during exercise and standing. Eur J Clin Invest 3: 199
Christensen NJ, Trap-Jensen J, Clausen JP, Noer J, Krogsgaard A, Larsen O (1975) Effect of beta-receptorblockade on heart rate hepatic blood flow and circulating noradrenaline during exercise in man. Acta Physiol Scand 95: 62
Christensen NJ, Galbo H, Hansen JF, Hesse B, Richter EA and Trap-Jensen J (1979) Catecholamines and exercise. Diabetes 28: Supplement 1: 58
Clausen JP, Trap-Jensen J, Lassen NA (1970) The effect of training on the heart rate during arm and leg exercise. Scand J Clin Lab Invest 26: 295
Clausen JP, Trap-Jensen J (1970) Effects of training on the distribution of cardiac output in patients with coronary artery disease. Circulation 42: 611
Cohen A, Watkins J, Mitas J, Schwartzman M, Cohen JM, Warren SE, Vieweg WV (1981) Clinical correlates in hypertensive patients with left ventricular hypertrophy diagnosed with echocardiography. Amer J Cardiol 47: 335
Colemann AJ, Leary WP (1972) Cardiovascular effects of acebutolol in exercising man: A comparative study with practolol and propranolol. Curr Ther Res 14: 673
Conway N, Seymor J, Gelson A (1968) Cardial failure in patients with valval heart disease after use of propranolol to control atrial fibrillation. Br Med J 2: 213
Corea L, Bentivoglio M, Verdecchia P, Prowidenza M, Motolese M (1984) Regression of left ventricular hypertrophy during metoprolol treatment. Int J Clin Pharmacol Ther Fox 22: 365
Costill DL, Fox EL (1969) Energetics of marathon running. Med Sci Sports 1: 81
Costill DL, Branam G, Eddy D, Sparks K (1971) Determinants of marathon running success. Int Z Angew Physiol 29: 249
Costill DL, Coyle F, Dalsky G, Evans W, Fink W, Hoopes D (1977) Effects of elevated plasma FFA and insulin on muscle glycogen usage during exercise. J Appl Physiol 43: 695
Courville C, Mason VR (1938) The heart in acromegalic. Arch Int Med 61: 704
Cruickshank JM (1980) The clinical importance of cardioselectivity an lipophilicity in beta blockers. Am Heart J100: 160
Cryer PE (1976) Isotrope derivative measurements of plasma norepinephrine and epinephrine in man. Diabetes 25: 1071
Csapo G, Weisswange A, Roskamm H (1978) Beta-Rezeptorenblocker bei atrioventrikulärem Block II. Grades. Intrakardiale elektrographische Untersuchungen an 9 Patienten. Z kardiol 67: 420
Cullinane E, Siconolfl S, Saritelli A, Thompson PD (1982) Acute decrease in serum triglycerides with exercise: is there threshold for an exercise effect? Metabolism 31: 844
Daskalopoulos N, Schmitt H (1975) Effect de l’acébutolol sur les structures cardiovasculaires centrales. Thérapie 30: 843–54
Davidson MB (1979) Effect of growth hormone administration to hypophysectomized rats on muscle lipid metabolism. Metabolism 28: 729–734
Day JL, Simpson N, Metcalfe J, Page RL (1979) Metabolic consequences of atenolol and propranolol in treatment of essential hypertension. Br Med J1: 77
Deacon SP, Barnett D (1976) Comparison of atenolol and propranolol during insulin-induced hypoglycaemia. Br Med J II: 272
De Gandpré R, Raab W (1953) Interrelated hormonal factors in cardiac hypertrophy; experiments in nonhypertensive hypophysectomized rats. Circulât Res 1: 345
Delius W, Wirtzfeld A, Dominiak P, Sebennig H, Blömer H, Grobecker H (1979) Effects of acute beta-adrenoceptor blockade on plasma norepinephrine concentration and hemodynamics in postmyocardial infarction patients. Z kardiol 68: 441–48
Detry JM, Rousseau M, Vandenbrouche G, Kusumi F, Brasseur LA, Bruce RA (1971) In creased arteriovenous oxygen difference after physical training in coronary heart disease. Circulation 44: 109
De Rose E, Romanowsky S, Rost R (1982) Die Auswirkungen unterschiedlicher Betarezeptoren-Blocker unter Ausdauerbelastung bei Gesunden und bei Diabetikern. Dtsch Z Sportmed 33: 222
Deutsche Liga zur Bekämpfung des hohen Blutdruckes (1976) Merkblatt, Empfehlungen zur Blutdruckmessung
Devereux RB, Reichek N (1977) Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55: 613
Devereux RB, Savage DD, Sachs I, Laragh JH (1980) Effect of blood pressure control on LV hypertrophy and function in hypertension (abstr). Circulation 62, Suppl II: 2
Devereux RB, Savage DD, Drayer J, Caragh J (1982) Left ventricular hypertrophy and function in high, normal, and low-renin forms of essential hypertension. Hypertension 4: 524
Devereux RB, Savage DD, Sachs I, Caragh J (1983) Relation of hemodynamic load to left ventricular hypertrophy and performance in hypertension. Amer J Cardiol 51: 173
Dick CB, Stone MC (1973) Prevalence of hyperlipoproteinemies in an random sample of men and in patients with ischemic heart disease. Br Heart J 35: 954
Diehm C, Mörl H, Schettler G (1983) Wirkungen von Propranolol und Metoprolol auf die periphere Durchblutung bei Claudicatio intermittens. Vasal2: 55
Dimsdale JE, Moss J (1980) Plasma catecholamines in stress and exercise. JAMA 243: 340
Distler A, Philipp Th (1976) Stellenwert der β-Rezeptorenblocker im Vergleich zu Diuretika in der Basistherapie der Hypertonie. Med Welt 26: 1022
Dole VP (1956) A relation between nonesterified fatty acids in plasma and the metabolism of glucose. J Clin Invest 35: 150
Dollery CT, Paterson W, Conolly ME (1969) Clinical pharmacology of beta-receptorblocking drugs. Clin Pharmacol Ther 1O: 765
Dominiak P, Kunkel G, Grobecker H (1980) Elevated plasma catecholamines in young hypertensive patients (Abstr). World Conference on Clinical Pharmacology and Therapeutics. London, p 506
Dorow P (1982) Effects of β-adrenoceptor blockade on carbohydrate metabolism during exercise. Comparison of pindolol and metoprolol. Br J Clin Pharmac 13:429 S
Drayer JIM, Gardin JM, Weber MA, Aranow WS (1982) Cardiac muscle mass during vasodilation therapy of hypertension. Clin Pharmacol Ther 32: 283
Drayer JIM, Gardin JM, Weber MA, Aranow WS (1982) Increases and decreases in ventricular septal thickness during diuretic therapy. Clin Pharmacol Ther 32: 283
Drews A (1967) Bedeutung und Ergebnisse ergometrischer Leistungskontrollen bei aktiver Bewegungstherapie. Arbeitsmed, Sozialmed, Arbeitshyg 2: 441
Dufey K, Krönig B (1974) Kritischer Belastungsblutdruck bei Hochdruckkranken. Ergebnisse direkter Blutdruckmessung unter alltäglichen und fahrradergometrischen Belastungen, Schlußfolgerungen für die Praxis. Fortschr Med 92: 1339
Dunn FG, Melville DI, Jones JV, Wrimer AR, Cawrie TDV (1973) Standardized stress and hypertension: comparison of effect of propranolol and methyldopa. Br J Clin Pharmac 5: 223
Dunn FG, Chandraratna P, de Carweko J, Basta L, Fröhlich E (1977) Pathophysiologic assessment of hypertensive disease with echocardiography. Amer J Cardiol 39: 789
Dunn FG, Cornier AR, Cawrie TDV (1979) Objective measurement of performance during acute stress in patients with essential hypertension: assessment of the effects of propranolol and metoprolol. Clin Sci 57: 413S
Eaton RP, Schade DS (1978) Modulation and implications of the counterregulatory hormones: glucagon, catecholamines, Cortisol and growth hormone. In: Katzen HM, Mahler RJ (eds) Diabetes, Obesity and Vascular Disease. Halstead, New York, pp 341–372
Editoral (1977) Beta blockers for diabetics. Lancet 1: 843
Editoral (1980) Fatigue as an unwanted effect of drugs. Lancet 1: 1285–1286
Ekblom B, Goldberg AN, Kilbom A and Astrand P-0 (1972) Effects of atropine and propranolol on the oxygen transport system during exercise in man. Scand J Clin Invest 30: 35
Ekelund LG, Ekelung C, Rössner S (1982) Antihypertensive effects at rest and during exercise of calcium blocker, nifedipine alone and in combination with metoprolol. Acta Med Scand 212: 71–75
Eliasson K, Ajemdahl P, Hylander B, Kahan T, Lins L-E (1982) Circulatory and sympathoadrenal responses after long-term beta-blockade. Abstract Ninth Scientific Meeting of the International Society of Hypertension. Mexico City
Empfehlungen zur indirekten Messung des Blutdruckes beim Menschen. Kommission der Deutschen Gesellschaft für Kreislaufforschung (1971). Z KreislaufforschgóO: 1
Engel FE and White JE (1960) Some hormonal influences on fat mobilization from adipose tissue. Am J Clin Nutr 8: 961
England JDF, Simons CA, Gibson JC (1980) The effect of metoprolol and atenolol on plasma high density lipoprotein levels in man. Clin Exp Pharm Physiol 7: 329
Ensinck JW, Williams RH (1974) Disorders causing hypoglycemia. In: Williams RH (Hrsg) Textbook of endocrinology S. 627, Saunders, Philadelphia
Epstein CC (1948) Extreme cardiac enlargement. Ann Int Med 48: 1387
Epstein SE, Robinson BF, Kahler RL, Braunwald E (1965) Effects of beta-adrenergic blockade on the cardiac response to maximal and submaximal exercise in man. J Clin Invest 44: 1745
Erikssen J, Jervell J (1975) A trial of a new adrenergic β-blocker, ICI66082, in the treatment of hypertension. Acta Med Scand 198: 49
Eriksson BO, Persson B, Thoreil JI (1971) The effects of repeated prolonged exercise on plasma growth hormone, insuline, glucose, lactate and ß-hydroxybutynic acid in 13-years old boys and in adults. Acta Paediatr Scand (suppl) 217: 142
Escher M, Heyden S, Christeller S, Gasser JP, Keller H, Ramsler L, Gsell O (1974) Hypertonie, Nikotinabusus, Hypercholesterinämie und Übergewicht bei Schweizer Männern 1973. Schweiz Med Wschr 104: 1423
Esler M, Leonhard P, Jackman G, Jennings G, Korner P (1982) Plasma noradrenaline measurements are a failible index of Sympathie nervous system activity in humans. Abstract Ninth Scientific Meeting of the International Society of Hypertension. Mexico City, p 109
Fain JN, Kovacev VP, Scow RO (1965) Effect of growth hormone and dexamethasone on lipolysis and metabolism in isolated fatt cells of the rat. J Biol Chem 240: 3522
Falkner B, Qiesti G, Affrime MB, Lowenthal DT (1982) The effect of a centralacting agent versus diuretics on the cardiovascular response to mental stress in adolescent hypertension. Abstract Ninth Scientific meeting of the International Society of Hypertension. Mexico City, pill
Fehm HL, Voigt KH, Pfeiffer EF (1972) Problems and artefacts in ACTH assay. Horm Metab Res 4: 477
Feigenbaum H (1981) Echocardiography. Lea u. Febinger, Philadelphia, 132
Feigl EO (1967) Sympathie control of the coronary circulation. Circ Res 20: 262
Felig P, Wahren J (1975) Fuel homeostasis in exercise. N Engl J Med 21: 1078–1084
Felig P, Cherif A, Minagawa A, Wahren J (1982) Hypoglycemia during prolonged exercise in normal men. N Engl J Med 306: 895
Fellenius E, Hedberg R, Karlsson N (1980) The effect of β-receptor blockade on adrenaline- induced changes in m. vastus lateralis and m.soleus of the rat in vivo. Acta Physiol Scand 110: 259
Fellenius E (1983) Muscle fatique and β-blockers. - A review. Int J Sports Med 4: 1
Floras JS, Fox P, Hassan MO, Jones JK, Sleight P, Turner KL (1979) Assessment of the antihypertensive effect of atenolol with 24 h ambulatory monitoring of blood pressure. Clin Science 57: 3875
Floras JS, Hassan MO, Sever PS, Jones JV, Osikowska B, Sleight P (1981) Cuff and ambulatory blood pressure in subjects with essential hypertension. Lancet II: 107
Folgering H (1980) Central β-adrenergic effects on the control of ventilation in cats. Respiration 39: 131
Folgering A, van Bussel M (1980) Maximal exercise power after a single dose of metoprolol and of slow-release metoprolol. Eur J Clin Pharmacol 18: 225
Folkow B (1975) Vascular changes in hypertension - review and recent animal studies. In: Berglund G, Hansson L, Werkö L (Hrsg) Pathophysiology and management of arterial hypertension, Mölndal/Schweden
Foster C, Costill DL and Fink WJ (1979) Effects of preexercise feedings on endurance performance. Med Sci Sports 11: 1
Fouad FM, Nakashima Y, Tarazi RC, Salcedo EE (1982) Reversal of left ventricular hypertrophy in hypertensive patients treated with methyldopa. Amer J Cardiol 49: 795
Friedewald WT, Levy RJ, Fredrickson DS (1972) Estimation of serum low density lipoprotein cholesterol concentration without the use of the preparative ultracentrifuge. Clin Chem 18: 499
Franz I-W, Lohmann FW (1977) Ergometrische Untersuchungen zur zusätzlichen Beurteilung der antihypertensiven Therapie. Verh Dtsch Ges Inn Med 83: 325
Franz I-W, Mellerowicz H (1977) Vergleichende Untersuchungen der PWC170 mit Leistungsstufen von unterschiedlicher Größe und Dauer. Z Kardiol 66: 670
Franz I-W (1978) Therapie der hypertonen Kreislaufregulationsstörungen bzw. Hypertonie durch dosiertes Training. Schw Z Sportmed 3: 117
Franz I-W, Lohmann FW, Koch G, Röcker L (1978) Der Einfluß sog. kardioselektiver und nichtkardioselektiver β-Rezeptorenblocker auf den Stoffwechsel während ergometrischer Leistung bei Hypertoniepatienten. Verh Dtsch Ges Inn Med 84: 813
Franz I-W, Lohmann FW, Koch G, Röcker L (1978) Die unterschiedliche Wirkung einer chronischen kardioselektiven und nicht kardioselektiven ß- Rezeptorenblockade auf den Plasma- katecholainspiegel während und nach standardisierter ergometrischer Leistung. Z Kardiol Suppl 5: 71
Franz I-W, Lohmann FW (1978) Die Bedeutung der ergometrischen Untersuchung zur Beurteilung der antihypertensiven Therapie. Dtsch Med Wschr 38: 1478
Franz I-W, Reinhart-Herdoiza (1978) Ergometry, physical training and hypertension. Kongreßband X XI. World Congress of Sports medicine, Brasilia
Franz I-W, Lohmann FW (1979) Der Einfluß einer Saluretikum-β-Rezeptorenblocker-Kombination auf überhöhte Belastungsblutdrücke. Med Klin 74: 396
Franz I-W (1979) Untersuchungen über das Blutdruckverhalten während und nach Ergometrie bei Grenzwerthypertonikern im Vergleich zu Normalpersonen und Patienten mit stabiler Hypertonie. Z Kardiol 68: 107
Franz I-W, Lohmann FW (1979) Der Einfluß einer chronischen kardioselektiven und nichtselektiven ß-Rezeptorenblockade auf den Blutdruck, die 02-Aufnahme und den Kohlenhydratstoffwechsel. Z Kardiol 68: 503
Franz I-W (1979) Welchen Sport dürfen und sollen Hypertoniker betreiben? Med Trib 36: 27
Franz I-W (1979) Indikationen, Dosierung und Kontraindikationen präventiven Trainings. In: Mellerowicz H, Franz I-W (Hrsg) Training als Mittel der präventiven Medizin, S. 27, Perimed, Erlangen
Franz I-W, Lohmann FW, Koch G (1979) Vergleichende Untersuchungen über die Wirkung einer chronischen kardioselektiven und nicht kardioselektiven Rezeptorenblockade auf die Plasmareninaktivität und den Blutdruck vor, während und nach Ergometrie bei Hochdruckkranken. Therapiewoche 29: 7753
Franz I-W, Lohmann FW, Koch G (1980) Differential effects of long-term cardioselective and nonselective beta-receptor blockade on plasma catecholamines during and after physical exercise in hypertensive patients. J Cardiovasc Pharmacol 2: 35
Franz I-W (1980) Differential antihypertensive effect of acebutolol and the fixed combination hydrochlorothiazide/amiloridehydrochloride on elevated exercise blood pressures in hypertensive patients. Am J Cardiol 46: 301
Franz I-W, Lohmann FW, Koch G (1980) Excessive dopamine increase at rest and during exercise after long-term betaadrenoreceptor blockade in hypertensive patients. Br Heart J 44: 25
Franz I-W, Mellerowicz H (1980) Vergleichende ergometrische Untersuchungen über den Tension-Time-Index und die körperliche Leistungsbreite bei Patienten mit grenzwertiger und stabiler Hypertonie und Normalpersonen. Z Kardiol 69: 587
Franz I-W, Lohmann FW, Koch G, Agrawal B (1980) Der Einfluß einer chronischen β-Rezep- torenblockade auf den Kohlenhydrat- und Fettstoffwechsel und deren hormonale Regulation bei Hochdruckkranken. Verh Dtsch Ges Inn Med 86: 105
Franz I-W, Lohmann FW (1980) Unterschiedlicher Einfluß einer chronischen, überwiegend β1 selektiven und β1- β2-Rezeptorenblockade auf den Kohlenhydratstoffwechsel. Ergometrische Untersuchungen bei Hochdruckkranken. Klin Wschr 58: 1155
Franz I-W (1980) Die antihypertensive Wirksamkeit einer fixen β-Rezeptorenblocker-Diureti- kum-Kombination auf Ruhe- und Belastungsblutdruck von essentiellen Hypertonikern. Schw Med Wschr 110: 1616
Franz I-W, Lohmann FW (1980) The effect of β-blockers on metabolism during exercise. In: Roskamm H, Graefe KH (eds) Advances in Blocker Therapy. Amsterdam, Oxford, Princeton, Excerpta Medica 45–54
Franz I-W, Lohmann FW, Agrawal B (1981) Beeinflussung des Belastungsblutdruckes 2,8 und 24 Stunden nach Gabe pharmakologisch unterschiedlicher β-Rezeptorenblocker bei chronischer Behandlung. Verh Dtsch Ges Inn Med 87: 518
Franz I-W (1981) Einfluß einer fixen β-Rezeptorenblocker-Diuretika-Kombination auf den hohen Blutdruck im Alter. Ergometrische Untersuchungen über das Blutdruckverhalten und den myokardialen 02-Verbrauch. Herz/Kreislauf 4: 187
Franz I-W (1982) Ergebnisse eines Expertengespräches. In: Krebs R, Aumiller J (Hrsg) Beta- Blocker: Leitlinien für die Praxis. MMW-Medizin Verlag, München
Franz I-W, Lohmann FW, Koch G (1982) Effects of chronic antihypertensive treatment with acebutolol and pindolol on blood pressure plasma catecholamines and oxygen uptake at rest an during submaximal and maximal exercise. J Cardiovasc Pharmacol 4: 180
Franz I-W (1982) Vergleichende ergometrische Untersuchungen über die Wirkung von β-Rezeptorenblockern und Diuretika und deren Kombination auf den Blutdruck und das Doppelprodukt bei Hochdruckkranken. Z Kardiol 71: 129
Franz I-W, Lohmann FW, Koch G (1982) Körperliche Leistungsfähigkeit und Plasmakate- cholamine während einer Kurz- und Langzeit-β-Rezeptorenblockade. Therapiewoche 46: 5730
Franz I-W, Lohmann FW (1982) Die Bedeutung ergometrischer Untersuchungen bei arterieller Hypertonie. Herz 7: 156
Franz I-W, Mellerowicz H (1982) Methodische und leistungsphysiologische Grundlagen der Ergometrie. Herz 7: 29
Franz I-W, Eismann D, Mellerowicz H (1983) Einfluß von Training und Gewichtsabnahme auf koronare Risikofaktoren. Kongreßband Dtsch Kongreß f Sportmed, Köln. Deutscher Ärzteverlag, S 283
Franz I-W, Quabbe H-J, Melier W, Mellerowicz H (1983) Lipolyse und Fettverbrennung und deren hormonelle Regulation bei Marathonläufern während einer Ausdauerbelastung. Kongreßband Dtsch Kongreß f Sportmed, Köln. Deutscher Ärzteverlag, S 283
Franz I-W, Koch G, Meiler W, Mellerowicz H (1984) Plasma catecholamines during steady- state exercise in marathon runners. Kongreßband XXII World Congress of Sports Medicine, Wien. Urban & Schwarzenberg, Wien, p 389
Franz I-W (1982) Ergometrie bei Hochdruckkranken. - Diagnostische und therapeutische Konsequenzen für die Praxis. Springer, Berlin Heidelberg New York
Franz I-W, Lohmann FW (1982) Reproduzierbarkeit des Blutdruckverhaltens während und nach Ergometrie bei Hochdruckkranken. Dtsch med Wschr 107: 1379
Franz I-W (1982) Welchen Stellenwert haben Sport und Bewegungstherapie im Therapiekonzept der Hypertonie? Sportmedizinische und präventive Aspekte. In: Matzdorff F, Nowacki PE (Hrsg) Tagungsbericht der Deutschen Gesellschaft für präventive und rehabilitative Kardiologie, Bad Nauheim. Perimed, Erlangen
Franz I-W (1982) Hypertonie und Sport. In: Rosenthal J (Hrsg) Arterielle Hypertonie. Springer, Berlin Heidelberg New York, zweite Auf!
Franz I-W (1983) Zur Wirkung des ai-Rezeptorenblockers Prazosin und des β-Rezeptorenblockers Acebutolol und deren Kombination auf den Blutdruck und das Doppelprodukt. Z Kardiol 72: 746
Franz I-W, Wiefel D (1984) Antihypertensive Wirkung von Calziumantagonisten auf Ruhe- und Belastungsblutdruck im Vergleich zu β-Rezeptorenblockern. 89. Tagung Dtsch Ges Innere Med, Wiesbaden. 89, S1138
Franz I-W (1983) Effect of acebutolol on elevated exercise blood pressure in hypertension. In: Lichtlen P, Maranhao M (Hrsg) 3rd International Beta Blocker Symposium Rio de Janeiro. Schattauer Verlag, Stuttgart, S147
Franz I-W (1983) Beeinflussung des Belastungsblutdruckes durch antihypertensive Pharmaka. In: Distler A, Philip T Neuere Entwicklungen in der Hochdrucktherapie. Schattauer, Stuttgart, S 71
Franz I-W, Lohmann FW, Röcker L (1984) Unterschiedlicher Einfluß einer chronischen β-selektiven und Rezeptorenblockade auf den Lipidstoffwechsel bei Hochdruckkranken. Herz/Kreislauf 3: 115–122
Franz I-W, Lohmann FW, Koch G, Quabbe H-J (1983) Aspects of hormonal regulation of lipolysis during exercise: effects of chronic ß-receptorblockade. Int J Sports Med 4
Franz I-W, Wiewel D, Ketelhut R (1984) Antihypertensiver Effekt einer β-blockierend und vasodilatorisch wirkenden Substanz auf Ruhe- und Belastungsblutdruck im Vergleich zur al- leinigen β-Rezeptorenblockade. Verh Dtsch Ges Inn Med Bd90: 750
Franz I-W, Ketelhut R, Behr U, Wiewel D (1985) Vergleichende Untersuchung zur Wirkung von Kalziumantagonisten und β-Rezeptorenblockern auf den Ruhe- und Belastungsblutdruck bei Hochdruckkranken. Klin Wsehr 63 (Suppl IV) 248
Franz I-W, Wiewel D, Behr U, Ketelhut R (1986) Ruckbildung der Myokardhypertrophie Hochdruckkranker unter chronischer p-Rezeptorenblockade. DMW 14: 530–534
Franz I-W, Behr U, Ketelhut R, Agrawal B (1986) Regression der Linksherzhypertrophie Hochdruckkranker durch Calziumantagonisten. Z Kardiol 75, Supple 1: 106
Freudenberg K (1962) GrundriB der medizinischen Statistik. Schattauer, Stuttgart
Frick MH, Katila M (1968) Hemodynamic consequences of physical training after myocardial infarction. Circulation 37: 192
Frisch P (1978) HerzgroBe, Puis und Blutdruck in Ruhe unter Atenolol. Med Klin 73: 1477
Frisk-Holmberg M, Juhlin-Dannfelt A, Jorsfeldt L, Astrom H (1976) Effect of long-term antihypertensive p-receptorblocking treatment on hemodynamic and metabolic responses to prolonged exercise in man. Clin Sci Mol Med 51: 489
Frisk-Holmberg M, Jorsfeldt L, Juhlin-Dannfelt A, Karlsson J (1976) Effect of long-term beta- blocking treatment on muscle metabolism in hypertensive man. Acta Physiol Scand (suppl) 480: 90
Frisk-Holmberg M, Jorsfeldt L, Juhlin-Dannfelt A, Astrom A (1977) Influence of alprenolol on haemodynamic and metabolic responses to prolonged exercise in subjects with hypertension. Clin Pharmacol Ther 21: 675
Frisk-Holmberg M, Ostman J (1977) Differential inhibition of lipolysis in human adipose tissue by adrenergic beta-receptor blocking drugs. J Pharmacol Exp Ther 200: 598
Frisk-Holmberg M, Jorsfeldt L, Juhlin-Dannfelt A, Kralson J (1979) Metabolic changes in muscle on long-term alprenolol therapy. In: Clin Pharmacol Ther 26: 566
Frohlich ED, Tarazi RC (1979) Is arterial pressure the sole factor responsible for hypertensive cardiac hypertrophy. Amer J Cardiol 44: 459
Fuchs G (1980) Umgang mit statistischen Zahlenangaben bei der arztlichen Begutachtungs- praxis. Lebensversicherungsmedizin 5: 115
Furberg C (1967) Adrenergic beta-blockade and physical work capacity. Acta Med Scand 182: 119
Galbo H, Hoist JJ and Christensen NJ (1975) Glucagon and plasma catecholamine responses to exercise in trained rats. J Appl Physiol 38: 70
Galbo H, Hoist J J, Christensen NJ and Hilsted J (1976) Glucagon and plasma catecholamines during beta-receptor blockade in exercising man. J Appl Physiol 40: 855
Galbo H, Richter EA, Hoist J J and Christensen NJ (1977) Diminished hormonal responses to exercise in trained rats. J Appl Physiol 43: 953
Galbo H, Christensen NJ, Hoist J J (1977) GlucoScinduced decrease in glucagon and epinephrine response to exercise in man. J Appl Physiol 42: 525
Galbo H, Richter EA, Hilsted J, Hoist JJ, Christensen N, Henriksson J (1977) Hormonal regulation during prolonged exercise. Ann NY Acad Sci 301: 72
Galbo H, Houston ME, Christensen NJ et al (1979) The effect of water temperature on the hormonal response to swimming. Acta Physiol Scand 105: 326
Garber AJ, Cryer PE, Santiago JV, Haymond MW, Pagliara AS and Kipnis DM (1976) Role of adrenergic mechanism in substrate and hormonal response to insulin-induced hypoglycemia in man. J Clin Invest 58: 7
Gerich JE, Corenzi M, Bier DM, Tsalikian E, Schneider V, Karam JH, Forsham PH (1976) Effect of physiological levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. J Clin Invest 57: 875
Ghosh P, Cochrane AMG, de Bono D (1975) Effects of long-term practolol therapy on plasma-lipids after acute myocardial infarction. Lancet 1: 9
Gibson DG (1974) Pharmacodynamic properties of beta-adrenergic receptor blocking drugs in man. Drugs 7: 8
Glatzel H (1980) Fettleibigkeit und soziale Sitation. Med Welt 31: 355
Gluck Z, Weidmann P, Mordasini R, Peheim E, Bachmann L, Keusch G, Riesen W (1979) Einfluß einer Diuretikatherapie auf die Serumlipoproteine: ein unerwünschter Effekt. Schweiz Med Wschr 109: 104
Goldberg LI (1972) Cardiovascular and renal actions of dopamine: Potential clinical applications. Pharmacology Review 24: 1
Goldberg MB, Lisser H (1942) Acromegaly: A consideration of its course and treatment. The J Clin Endocrinol 2: 477
Goldstein JL, Hazzard WR, Schrolt HG, Biermann L, Motoulsky AG (1973) Hyperlipemia in coronaiy heart disease. J Clin Invest 52: 1553
Gollnick PD (1973) Factors controlling glycogenolysis and lipolysis during exercise. In: Keul J (Hrsg) Limiting factors of physical performance. Georg Thieme, Stuttgart, S 81
Goodman HM (1967) Effects of growth hormone on glucose utilization in diaphragma muscle in the absence of increated lipolysis. Endocrinology 81: 1099–1103
Gordon DA, Hill FM, Ezrin C (1962) Acromegaly: A revies of 100 cases. Canad Med Ass J 87: 1106
Gordon T, Calstelli WP, Hjostland MC, Kannel WB, Dawber TR (1977) High density lipoprotein as a protective factor against coronary heart disease. Am J Med 62: 707
Granath A, Jonsson B, Strandell T (1964) Circulation in healthy old men, studied by right heart catheterization at rest and during exercise in supine and sitting position. Acta Med Scand 176: 425
Greenblatt DJ, Koch-Weser J (1973) Adverse reaction to propranolol in hospitalized medical patients. A report from the Boston Collaborative Drug, Surveillance Program. Am Heart J 86: 478
Greenwood FC, Landon J (1966) Growth hormone secretion in response to stress in man. Nature 210: 540
Grimby G, Smith U (1978) β-blockade and muscle function. Lancet II: 1318
Grobecker H, Planz G, Wiethold G, Simsrock R, Becker HJ, Lutz E, Petersen P (1976) Specific and non-specific effects of ß-adreno-receptor blocking drugs in man. Klin Wschr 54: 783
Groop L, Töltermann KJ, Harno K, Gordin H (1983) Influence of beta-blocking drugs on glucose metabolism in hypertensive, non-diabetic patients. Acta Med Scand 213: 9
Groß F (1974) Drug therapy in hypertension. What we have, what we need, what we except. Am J Cardiol 34: 471
Groß F (1978) Klinische Pharmakologie der β-Adrenozeptoren Blocker. Internist 19: 504
Gross SR, Nayer SE (1974) Regulation of Phosphorylase B to A conversion in muscle. Life Sci 14: 401–14
Gugler R (1978) Therapie mit Beta-Rezeptorenblockern. Nebenwirkungen und Kontraindikationen. Internist 19: 547
Haggendahl LL, Hartley H and Saltin B (1970) Arterial noradrenaline concentration during exercise in relation to relative work levels. Scand J Clin Lab Invest 26: 337
Halhuber MJ (1966) Längsschnittuntersuchungen an Hochdruckkranken während einer Klima- und Terrainkur in 2000 m Höhe. Sportarzt und Sportmed 17: 473
Hansson BG, Hökfelt B (1975) Long-term treatment of moderate hypertension with pentubo- lol. Eur J Clin Pharmacol 9: 9
Hansson BG (1976) Long-term non-selective and cardio-selective receptor blockade in hypertensive patients. Acta Med Scand Suppl 598: 1
Hansson BG, Dymling JF, Hedeland H, Hulthen UL (1977) Long term treatment of moderate hypertension with the betarreceptor blocking agent metoprolol. Eur J Clin Pharmacol 239 und 247
Harms HH, Gooren L, Spoelstra AJ, Hesse C (1978) Blockade of isoprenaline-induced changes in plasma free fatty acids, immuno-reactive insulin levels and plasma renin activily in healthy human subjects by propranolol, pindolol, practolol, atenolol, metoprolol and acebutolol. Br J Clin Pharmac 5: 19
Harri MNB (1979) Physical training under the influence of beta-blockade in rats. II Effects on vascular reactivity. Eur J Appl Physiol 42: 151
Harris L, Dargie HJ, Lynch PG, Bulpitt J, Krikler DM (1982) Blood pressure and heart rate in patients with ischemic heart disease receiving infedipin and propranolol. Brit Med J 284: 1148
Harry JD, Knapp MF, Linden RJ, Stoker JB, Newcombe L (1979) Effects of 4 β-adrenoceptor-blocking drugs on blood pressure and exercise heart rate in hypertension. Eur J Cardiol 10: 131
Hartley LH, Mason JW, Hogan RP (1972) Multiple hormonal responses to graded exercise in relation to physical training. J Appl Physiol 33: 602
Hartley LH, Masin JW, Hogan RP (1972) Multiple hormonal responses to prolonged exercise in relation to physical training. J Appl Physiol 33: 607
Hartling OJ, Noer I, Svendsen TL, Clausen JP and Trap-Jensen J (1980) Selective and non-selective beta-adrenoceptor blockade in the human forearm. Clin Sci 58: 279
Hasselbach HC, Beck K, Eskildsen PC (1981) Serum prolactin and thyrotrop in responses to thyrotropin-releasing-hormone in men with alcoholic cirrhosis. Acta Med Scand 209: 37
Hauss WH (1982) Zur Pathogenese der Arteriosklerose. Med Welt 33: 20
Havel JR, Carlson LA, Ekelund L-G, Holmgren A (1973) Turnover rate and oxidation of different free fatty acids in man during exercise. J Appl Physiol 19: 613
Helmreich EJM (1976) Hormone-receptor interactions FEBS. Letters 61: 1
Herberg L, Berger M, Gries FA (1974) Comparative investigations on lipolysis and reesterification in adipose tissue of man and various species of mice. Comp Biochem Physiol (A) 48: 163
Hessler JR, Robertson AL, Chrisholm GM III (1979) LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. Atherosclerosis 32: 213
Heyden S (1974) Ergebnisse und Konsequenzen der Post-Framingham-Studie. Risikofaktoren für das Herz. Mannheim
Hickson RG, Rennie MJ, Conlee RK (1977) Effects of increased plasma free fatty acids on glycogen utilization and endurance. J Appl Physiol 43: 829
Hilsted J, Galbo H, Christensen NJ (1980) Impaired responses of catecholamines, growth hormone and Cortisol to graded exercise in diabetic autonomic neuropathy. Diabetes 29: 257
Hirth-Schmidt H, Raptis S, Schröder KE, Pfeifer EF (1973) Die Wirkung der Beta-Rezeptoren- blocker Pindolol (LB 46) und Beta-Adrenol (KL 255) auf die durch Argenin und Muskelarbeit induzierte Wachstumshormonsekretion beim Menschen. In: Beringer H (Hrsg) 3. Internationales Donau-Symposium. Mandrich, Wien München Bern, S 781
Hochdruck-Ratgeber: Sport und Bewegung. Bayer AG, Pharma Wiss Abteilung
Hodge JV, Smirk FH (1967) The effect of drug treatment of hypertension on the distribution of deaths from various causes. Am Heart J 73
Holland OB, Nixon JV, Kuhnert L (1981) Diuretic-induced ventricular ectopic activity. Amer J Med 70: 762
Hollmann W, Barg W, Weyer G, Heck H (1970) Der AlterScinfluß auf spiroergometrische Meßgrößen im submaximalen Arbeitsbereich. Med Welt 21: 1280
Hollmann W (1974) Leistungsphysiologische Grundlagen zur rehabilitativen Kardiologie. In: Mellerowicz H, Weidener J, Jokl E (Hrsg) Rehabilitative Kardiologie, S. 44. Karger, Basel
Holm G, Herlitz J, Smith U (1981) Severe hypoglycaemia during physical exercise and treatment with beta-blockers. Brit Med J 282: 1360
Holloszy JO, Mole PA, Baldwin KM, Teijung RL (1973) Exercise induced enzymatic adaptations in muscle. Keul J (Hrsg) In: Limiting factors of physical performance. Georg Thieme, Stuttgart, S 66
Holmgren A (1956) Circulatory changes during mucular work in man. With special reference to arterial and central venous pressures in the systematic circulation. Scand J Clin Lab Invest 8, Suppl 24: 1
Hornung RS, Gould BA, Kieso HA, Raftery EB (1981) The effect of Modueren on 24 hour blood monitoring. Abstract, Symposium: Potassium, the Heart and Hypertension, Rome
Hultmann EL, Nilsson L (1974) Liver glycogen as a glucose-supplying source during exercise. In: Keul J (Hrsg) Limiting factors of physical performance, S. 179. Thieme, Stuttgart
Hunter WM, Fonseka CC, Passmore R (1965) Growth hormone: important role in muscular exercise in adults. Science 150: 1051
Hypertension Detection and Follow-up Program Cooperative Groups (1979) Five-year findings of the Hypertension Detection and Follow-up Program. I. Reduction on mortality of persons with high blood pressure including mild hypertension. J Am Med Ass 242: 2562
Hypertension Detection and Follow-up Program Cooperative Group (1979) Five-year follow- up Program. II. Mortality by race, sex and age. J Am Med Ass 242: 2572
Ibrahim MM, Madkour MA, Mossallam R (1980) Effect of atenolol on left ventricular function in hypertensive patients. Circulation 62: 1036
Ibrahim MM, Madkour MA, Mossallam R (1981) Factors influencing cardiac hypertrophy in hypertensive patients. Clin Sci 61: 105
Ireland MA, Littler WA (1981) The effects of oral acebutolol and propranolol on forearm blood flow in hypertensive patients. Br J Clin Pharmae 12: 363
Irving MH, Britton BJ, Wood WG, Padgham C, Carruthers M (1974) Effects of adrenergic blockade in plasma catecholamines in exercise. Nature 248: 531
Isbary J, Greding H, Nechwatal W, König B (1978) Hämodynamische Veränderungen bei Hypertonikern nach Sympathikolyse mit Propranolol und Metoprolol. Z Kardiol 67: 857
Issekutz B (1978) Role of beta-adrenergic receptors in mobilization of energy sources in exercising dogs. J Appl Physiol 44: 869–876
Jahnecke J (1974) Risikofaktor Hypertonie. Mannheim
Jakob AF (1977) Energiestoffwechsel und Regulation des hepatischen Glykogen-Umsatzes durch Hormone. Fortschr Med 95: 1923–1926
Johnson W, Grover J (1967) Hemodynamic and metabolic effects of physical training in four patients with essential hypertension. Canad Med Ass J 96: 842
Johnsson G (1975) Influence of metoprolol and propranolol on hemodynamic effects induced by adrenaline and physical work. Acta Pharmacol Toxicol 36 (Suppl V): 59
Jokl E, Ball M, Frankel L (1967) Ergometry, exercise and hypertension. In: Mellerowicz H, Hansen G (Hrsg) 2. Int Seminar für Ergometrie. Ergon
Jörgensen CR, Wang K, Gobel FL (1974) Effect of propranolol on myocardial oxygen consumption during static and dynamic exercise. Circulation 50: 1179
Jürgensen HJ, Meinertz H, Faergeman O (1982) Plasma lipids and lipoproteins in long-term beta-adrenergic blockade. Acta Med Scand 211: 449
Julius S, Pascual AV, Sannerstedt R (1971) Relationship between cardiac output and peripheral resistance in borderline hypertension. Circulation 43: 382
Juhlin-Dannfelt A, Frisk-Homberg M, Karlsson J, Tesch P (1979) Central and peripheral circulation in relation to muscle fibre composition in normo- and hypertensive man. Clin Sci 56: 335
Juhlin-Dannfelt A (1982) Metabolic effects of ß-adrenoreceptor blockade on skeletat muscle at rest and during exercise. Acta Med Scand (Suppl 66 ): 113
Juhlin-Dannfelt A (1983) β-adrenoceptor blockade and exercise: effects on endurance and physical training. Acta Med Scand (suppl 672): 49
Junges FL, Ball EG (1963) Studies on the metabolism of adipose tissue. XII. The effects of insulin and epinephrine on free fatty acid and glycerol production in the presence and absence of glucose. Biochemistry 2: 383
Kaiser P, Rössner S, Karlsson J (1981) Effect of β-adrenergic blockade on endurance and short-time performance in respect to individual muscle fibre composition. Int J Sports Med 2: 37
Kannel WB, Widmer LK, Dawber TR (1965) Gefährdung durch coronare Herzkrankheit. Folgerungen für die Praxis aus 10 Jahren Framigham-Studie. Schweiz Med Wschr 95: 18
Kannel WB, Gordon T, Schwartz MJ (1971) Systolic versus diastolic blood pressure and risk of coronary disease. Am J Cardiol 27: 335
Kannel WB, Castelli WP, Gordon T (1979) Cholesterol in the prediction of artherosclerotic disease. Ann Intern Med 90: 85
Kannel WB, Castelli WP, McNamara PM, McKee PA, Feinleib M (1972) Role of blood pressure in the development of congestive heart failure. N Engl J Med 287: 781
Karlsson J, Bonde-Petersen F, Henriksson J, Knuttgen HG (1975) Effects of previous exercise with arms or legs on metabolism and performance in exhaustive exercise. J Appl Physiol 38: 763
Kaul M, Mohan JC, Bhatia M (1984) Effects of labetalol on left ventricular mass and function in hypertension. - An assessment by serial echocardiography. Int J Cardiol 5: 461
Kathri J, Gottdiener J, Notargiacomo A, Freis E (1980) Effect of therapy on left ventricular function in hypertension. Clin Sci 59: 436
Kellermann JI, Ben-Ari E, Chaquet M, Lapidot C, Drory Y, Fisman E (1977) Cardiocirculatory response to different typs of training in patients with angina pectoris. Cardiology 62: 218
Keul J, Haralambie G (1971) Die chronischen Effekte des körperlichen Trainings auf den Stoffwechsel. Verh Dtsch Ges Kreisl-Forsch 37: 101
Keul J, Huber G, Kindermann W, Burmeister P, Petersen KG (1976) Die Wirkung eines neuartigen β-Rezeptorenblockers ( Bunitrilol) auf Kreislauf und Stoffwechsel unter extremen Streßbedingungen. Med Welt 27: 437
Keul J, Huber G, Maas A, Blessing W, Westermann H, König K (1976) Der Einfluß des ß- Blockers Bunitrol auf metabolische, hormonelle und kardiozirkulatorische Veränderungen bei Herzkranken während des Fernsehens. In: Herz/Kreisl 8: 578
Kiesewetter R (1982) Ergebnisse der Spiroergooxytensiometrie vor und nach antihypertensiver Behandlung. Med u Sport 22: 168
Kilpatrick JA (1978) The variaton of casual, basal, and supplemental blood pressure in health and in essential hypertension. Br Heart J10: 48
Kindermann W, Schmitt WM, Biro G, Schnabel A (1981) Metabolismus und hormonelles Verhalten bei Körperarbeit unter akuter Betar Sympathikolyse. Z Kardiol 70: 406
Kissebah AH (1974) Stress hormones and lipid metabolism. Proc R Soc Med 67: 665
Kitamura K, Jörgensen CR, Göbel F (1972) Hemodynamic correlates of myocardial oxygen consumption during upright exercise. J Appl Physiol 32: 516
Klein W, Mlekusi E, Härringer M (1982) Kalziumantagonisten zur Behandlung der chronischen arteriellen Hypertonie. Herz/Kreisl 5: 247
Klose G, Grefen H (1980) Schützt HDL-Cholesterin vor Herzinfarkt? Med Klin 75: 67
Knauf H (1969) Die Wirkung der Betarezeptorenhemmstoffe auf die Durchblutung des arbeitenden Skelettmuskels. Z Kreislaufforsch 58: 749
Koch G (1977) Plasma renin activity, epinephrine and norephephrine at rest and during exercise in young adults and boys. Scand J Clin Lab Invest Suppl 147: 37, 107
Koch G (1978) Plasma catecholamines and plasma renin activity during submaximal and near- maximal exercise in normotensive adolescents and adults, and in hypertensive patients. (Abstr) Fifth Scientific Meeting of the International Society of Hypertension, S140
Koch G, Johansson U, Arvidsson E (1980) Determination of epinephrine, norepinephrine and dopamine in 0,1 ml plasma samples. J Clin Chem Clin Biochem 18: 367
Koch G, Franz I-W, Gubba A, Lohmann FW (1983) β-adrenoceptor blockade and physical activity: cardiovascular and metabolic aspects. Acta Med Scand (suppl 672 ): 55
Kölendorf K, Bonnevie-Nielsen V, Broch-Möller B (1982) A trial of metoprolol in hypertensive insulindependent diabetic patients. Acta Med Scand 211: 175
König K, Gebhardt W, Ulimann HW, Reindell H (1968) Veränderungen des Herzvolumens sowie einiger wichtiger spiroergometrischer Parameter nach β-Rezeptorenblockade. Z Kreisl- Forschg 57: 415
König K, Ruck H, Brusis O (1977) Der Effekt körperlichen Trainings im Rahmen der Frührehabilitation nach Herzinfarkt. Herz/Kreisl 4: 192
Koerker DJ, Goodner CJ, Toivola PTK, Gale CC and Ensink JW (1974) Adaption to fasting in baboon. I. Influence of feeding schedule. Am J Physiol 227: 520
Koerker DJ, Goodner CD, Chideckel EW and Ensink JW (1975) Adaption to fasting in baboon. II. Regulation of lipolysis early and late in fasting. Am J Physiol 229: 350
Koivisto VA, Karonen S-L, Nikkilä EA (1981) Carbohydrate ingestion before exercise: comparison of glucose, fructose and sweet placebo. J Appl Physiol 51: 783
Kolloch R, Stumpe KO, Higuchi M, Vetter H, Krück F (1977) Erhöhte Plasma-Prolactin-Konzentration bei essentieller Hypertension: Index einer verminderten hypothamalischen dop- aminergen Aktivität. Klin Wschr 55: 20, 1013
Kolloch R, Myers M, Bornheiner J, de Quattro V (1981) Hämodynamik und Katecholamine während statischer Muskelarbeit bei essentieller Hypertonie. Einfluß kombinierter a- und ß- Rezeptorenblockade. 87. Verh Dtsch Ges Inn Med
Kotler MN, Bermann L, Rubinstein AH (1966) Hypoglycaemia precipitaded by Propranolol. Lancet 1: 1389
Krönig B (1976) Blutdruckvariabilität bei Hochdruckkranken. Hüthig, Heidelberg
Kumana CR, Marlin GE, Kaye CM and Smith DM (1974) New approach to assessment of cardioselectivity of beta-blocking drugs. Br Med J 4: 444
Lager I, Blohme G, Smidt U (1979) Effect of cardioselective and nonselective β-blockade on the hypoglycaemic response in insulin-dependent diabetics. Lancet 3: 458
Lake CR, Ziegler MG, Kopin IJ (1976) Use of plasma norepinephrine for evaluation of sympathetic neurologic function in man. Life Sci 18: 1315
Lands AM, Arnold A, McAuliff JP, Luduena FP, Brown TG (1967) Differention of receptor systems activated by sympathomimetic amines. Nature 214: 597
Leary WP (1974) The cardioselectivity of acebutolol in man. Clin Trials J11: 33
Leenen FHH, Coener CHM, Zondersland M, Maas AHJ (1980) Effects of cardioselective and nonselective β-blockade in dynamic exercise performance in mildly hypertensive men. Clin Pharmacol Ther 28: 12
Lehmann M, Keul J, Löllgen H, Just H (1981) Plasmakatecholamine und Hämodynamik bei gestörter linksventrikulärer Funktion in Ruhe und bei Belastung. Z Kardiol 70: 238
Lehmann M, Keul J, Wybitul K (1980) Belastungsabhängige Veränderungen der Plasmakatecholamine unter Bunitrolol und Methypranol. Beeinflussung von Lipolyse- und Glycogenolyse.Z Kardiol 9: 242
Lehmann M, Keul J, Wybitul K, Fischer H (1982) Auswirkung einer selektiven und nicht selektiven Adrenozeptorenblockade während Körperarbeit auf den Energiestoffwechsel und das sympathoadrenerge System. Arzneim-Forsch 32: 261
Lehtonen A, Viikari J (1979) Longterm effects of soltalol on serum lipids. Clin Sci 57: 405s
Leitch AG, Hopkin JM, Ellis DA, McClarkson G, Merchant S and McHardy GJR (1980) Failure of propranolol and metoprolol to alter ventilatory responses to carbon dioxide and exercise. Br J Clin Pharmacol 9: 493
Leren P, Helgeland A, Holme J, Foss PO, Hjerman I, Lund-Larsen PG (1980) Effects of propranolol and prazosin on blood lipids. The Oslo Study. Lancet 2: 4
Lerner RL, Porte D (1971) Epinephrine: Selective inhibition of the acute insulin response to glucose. J Clin invest 50: 2453
Lie JT, Grossman SJ (1980) Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patients. Am Heart J100: 41
Liesen H (1974) Körperliches Training und Beta-Rezeptorenblockade. In: Mellerowicz H, Weidener J, Jokl E (Hrsg) Rehabilitative Kardiologie. Basel
Lindström L, Magnusson R, Petersen I (1979) Muscular fatigue and action potential conduction velocity changes studies with frequency analysis of EMG signals. Electromyogr 4: 341
Littler WA, Honour AJ, Pugsley DJ, Sleight P (1975) Continous recording of direct arterial pressure in untreated patients: its role in the diagnosis and management of high blood pressure. Circulation 51: 1101
Lloyd-Mostyn RH, Oram S (1975) Modification by propranolol of cardiovascular effects of induced hypoglycaemia. Lancet 1: 1213–1215
Lloyd-Mostyn RH, Lefevre D, Lord PS, Doig E, Krikler DM (1981) The effect of beta-adrenergic blocking agents on serum lipids. Atherosclerosis 14: 283
Lockwood RH, Lum BKB (1974) Effects of adrenergic agonists and antagonists on potassium metabolism. J Pharmacol Exp Ther 189: 119
Lohmann FW (1981) Die Beeinflussung des Stoffwechsels durch Beta-Rezeptoren-Blocker. Klin Wschr59: 49
Lohmann FW (Hrsg) (1982) β-Rezeptorenblockade. Springer
Lorimer AR, Barbour MP, Comerfield MB, Lawrie DV (1982) Assessment of blood pressure responses in hypertension to isometric and varying form of dynamic exercise, and their modification by treatment. Abstract Ninth Scientific meeting of the International Society of Hypertension. Mexico City, p 252
Loubatieres A, Mariani MM, Sorel G, Savi L (1971) The action of β-adrenergic blocking and stimulating agents of insulin secretion. Characterization of the type of β-receptor. Diabetologia 7: 127
Lüderitz B (1978) Beta-Rezeptorenblocker bei kardialen Rhythmusstörungen. Internist 19: 532
Lundborg P, Aström H, Bengtsson C, Fellenius E, v Schenk H, Svensson L, Smith U (1981) Effect of β-adrenoceptor blockade on exercise performance and metabolism. Clinical Science 61: 299
Lund-Johansen P (1967) Hemodynamics in early essential hypertension. Acta Med Scand 183, Suppl 482: 1
Lund-Johansen P, Ohm OI (1976) Hemodynamic long-term effects of β-receptor blocking agents in hypertension: Comparison between alprenolol, atenolol and timolol. Clin Sci Mol Med 51: 481
Lund-Johansen P (1976) Hemodynamic effects of Clonidine in man. In: Onesti G, Fernandes M, Kim KE (Hrsg) Regulation of blood pressure by the central nervous system. Grune u Stratton, New York
Lund-Johansen P (1979) Hemodynamic consequences of long-term beta-blocker therapy: a 5 year follow-up study of atenolol. J Cardiovasc Pharmacol 1: 487
Lund-Johansen P (1980) Hämodynamik bei der essentiellen Hypertonie in Ruhe und während Ergometrie und deren Beeinflussung durch Diuretika, β-Rezeptorenblocker und Vasodilatatoren. In: Franz I-W (Hrsg) Belastungsblutdruck bei Hochdruckkranken. Springer, Berlin Heidelberg New York, S107
Lundvall J, Järhult J (1976) Beta-adrenergic dilator component of the symathetic vascular response in skeletal muscle. Acta Physiol Scand 96: 180
Lydtin H Welcher Sport ist für den Hypertoniker empfehlenswert? Sandoz-Reihe: Experten beantworten Fragen zur Hypertonie
Mäurer W, Schöming A, Kaden F, Dietz R (1978) Effect of propranolol and bunitrolol on symathic activity. Verh Dtsch Ges Inn Med 84: 468
Maksud MG, Tristani FE, Coolls KO, Barboriak JJ, Hamilton LH (1970) Effect of propranolol on several physiological responses during orthostatic and exercise stress in healthy male subjects. Can J Physiol Pharmacol 49: 867
Malek I, Waagstein F, Hjalmarson A, Holmberg S (1978) Hemodynamic effects of the cardio- selective β-blocking agent metoprolol in acute myocardial infarction. Acta Med Scand 204: 195
Management Comittee (1980) The Australian therapeutic trial in mild hypertension. Lancet 10: 1261
Mann S, Millar-Crong MW, Altmann DG, Melville D, Raftery EB (1979) The effects of metoprolol and ambulatory blood pressure. Clin Science 57: 375s
Matthes D, Schütz P, Hüllemann K-D (1978) Unterschiede zwischen indirekt und direkt ermittelten Blutdruckwerten. Med Klin 11: 371
Mayer S, Moran NC, Fain J (1961) The effect of adrenergic blocking agents on some metabolic actions of catecholamines. J Pharmacol Exp Hier 134: 18
McAllister RG (1979) Effects of adrenergic receptor blockade on the responses to ergometrie handgrip: Studies in normal and hypertensive subjects. J Cardiovasc Pharmacol 1: 253
McDonald RH Jr, Goldberg LI, McNay JL and Tuttle EP Jr (1964) Effect of dopamine in man. Argumentation of sodium excretion, glomerular filtration rate and renal plasma flow. J Clin Invest 43: 1116
McFate Smith W (1977) Treatment of mild hypertension. Results of a ten-year intervention trial. Circ Res 40, Suppl I: 1
McSorley PD and Warren DJ (1978) Effects of propranolol and metoprolol on the peripheral circulation. Br Med J 2: 1598 - 1600
Mellerowicz H (1956) Vergleichende Untersuchungen über das Ökonomieprinzip in Arbeit und Leistung des trainierten Kreislaufs und Scine Bedeutung für die präventive und rehabilitative Medizin. Arch Kreisl Forsch 24: 70
Mellerowicz H (1979) Ergometrie. 3. neubearb Aufl. Urban & Schwarzenberg, München Wien Baltimore
Merimce TJ, Rabin O (1973) A survey of growth hormone secretion and action. Metab Clin Exp 22: 1235
Merker R, Schwittek W, Kladetzky R-G, Kuhn H (1981) Serumlipide unter chronischer Behandlung mit β-Rezeptorenblockern bei Patienten mit Herzkrankheit. Z Kardio 70: 455
Mertz DP (1980) Atherosklerose-Index (LDL/HDL): Risikoindikator bei Störungen des Fettstoffwechsels. Med Klin 75: 159
Messerli FH, Ventura HO, Glade LB, Sundgaard-Rüse K, Dunn FG, Fröhlich E (1983) Essential hypertension in the elderly: haemodynamics intravascular volume, plasma reninactivity, and circulating catecholamine levels. Lancet II: 983
Metropolitan Life Insurance Company (1961) Blood pressure: Insurance experience and its implications. New York
Miall WE, Bell RA, Lovell HG (1968) Relation between changes in blood pressure and weight. Br J Prev Soc Med 22: 73
Middecke M, Burkhart A, Holzgreve H (1982) Blutdruckverhalten während dynamischer und isometrischer Belastungen unter antihypertensiver Langzeittherapie mit Beta- Rezeptorenblokkern und Diuretika. 88. Verh Dtsch Ges Inn Med 737
Miettinen T, Huttmann JK, Ehnholm C, Kumlin T, Mattila S, Naukkarinen V (1980) Effect of long-term antihypertensive and hypolipidemic treatment on high density lipoprotein cholesterol and apoliproteins A-I and A-II. Atherosclerosis 36: 249
Molé PA, Oscai LB, Holloszy JO (1971) Adaptation of muscle to exercise. Increase in the levels of palmityl CoA synthetase, caraitic palmityl-transferase, and palmityl CoA dehydrogenase, and in the capacity to oxidize fatty acids. J Clin Invest 50: 2323
Moratinos J, Potter DE, Ellis S (1975) The influence of propranolol on catecholamine. Induced changes in carbohydrate metabolism in the rabbit. Eur J Pharmacol 32: 186
Mordasini R, Glück Z, Weichmann P, Keusch G, Meyer A, Riesen W (1980) Zur Pathogenese der Diuretika-induzierten Hyperlipoproteinämie. Klin Wschr 58: 359
Morgan T, Adam W, Carney S, Gibbard R, Brown S, Wheeler D (1979) Treatment of mild hypertension in elderly males. Clin Sci 75: 355s
Morganti A, Pickering TG, Lopez-Ovejero JA, Laragh JH (1979) Contrasting effects of acute betablockade with propranolol on plasma catecholamines and renin in essential hypertension. Am Heart J 98: 490
Morgenroth J, Maron BJ, Henry WL, Epstein SE (1975) Comparative left ventricular dimension in trained athlets. Am Intern Med 82: 521
Mortimer JT, Magnusson R, Petersen K (1970) Conduction velocity in ischemic muscle: Effect on EMG frequency spectrum. Am J Physiol 219: 1324–1329
Moser L, Schmidt M, Lundt PV (1979) Die Wirkungen eines Beta-Rezeptorenblockers auf die Kraftfahreigenschaft. Med Klin74: 1134
Muir GG, Chamberlain DA, Tunstall Pedoe D (1964) Effects of β-sympathetic blockade on non-esterifled-fatty-acid and carbohydrate metabolism at rest and during exercise. Lancet 10: 930–932
Nakamura Y, Schwartz A (1972) The influence of hydrogen ion concentration on calcium binding and release by skeletal muscle-sacroplasmic reticulum. J Gen Physiol 59: 22
Nakashima J, Fouad F, Tarazi R(1984) Regression of left ventricular hypertrophy from systemic hypertensive by enalapril. Amer J Cardiol 53: 1044
Nelson RR, Gobel FL, Jörgensen CR (1973) Hemodynamic predictors of myocardial oxygen consumption during static and dynamic exercise. Circulation 50: 1173
Nerem RM, Cornhill JF (1980) Hemodynamics and atherogenesis. Atherosclerosis 36: 151
Nilsson A, Hansson B-G, Hokfelt B (1978) Effect of metoprolol on blood glycerol, free fatty acids, triglycerides and glucose in relation to plasma catecholamines in hypertensive patients at rest and following submaximal exercise. Europ J Clin Pharmacol 13: 5
Nyberg G (1976) Effect of ß-adrenoreceptor blockers on heart rate and blood pressure in dynamic and isometric exercise. Drugs 11 (Suppl 1): 185
Opie LH (1980) Drugs and the Heart. III.Calcium antagonists. Lancet 2: 806–810
Palm D (1977) Adrenerge β-Rezeptoren und β-Rezeptorenblocker. In: Hierholzer K, Rietbrock N (Hrsg) Perimed, Erlangen
Patrick JM and Pearson SB (1980) Beta-adrenoceptor blockade and ventilation in man (Letter). Br J Clin Pharmacol 10: 624–625
Patyna WD (1981) Die Beeinflussung des Blutdruckverhaltens Hochdruckkranker während Ergometrie durch eine Reserpin-Diuretikum-Kombination und β-Rezeptorenblocker. In: Franz I-W (Hrsg) Belastungsblutdruck bei Hochdruckkranken. Springer, Berlin Heidelberg New York, S139
Pearson SB, Banks DC and Patrick JM (1979) The effect of beta-adrenoceptor blockade on factors affecting exercise tolerance in normal man. Br J Clin Pharmacol 8: 143
Pedersen EB, Christensen NJ (1975) Catecholamines in plasma and urine in patients with essential hypertension, determined by double isotope derivative techniques. Acta Med Scandl 98: 373
Pernow B, Saltin B (1971) Availability of substrates and capacity for prolonged heavy exercise in man. J Appl Physiol 31: 416
Philipp Th, Cordes U, Distler A (1977) Sympathetic responsiveness and antihypertensive effect of betareceptor blockade in essential hypertension. Dtsch Med Wschr 102: 569
Philipp Th, Distler A (1979) Gefaßreagibilität unter Diuretika. Med Welt 26: 1015
Pickering TG, Harshfield GA, Kleinen HD, Blank S, Laragh JH (1982) Blood pressure during normal daily activities, sleep and exercise. JAMA 247: 992
Pietro DA (1981) Reproducibility of echocardiography. Chest 79: 29
Pinter EJ and Pattee CP (1967) Effect of β-adrenergic blockade on resting and stimulated fat mobilization. J Clin Endocrinol 27: 1441
Pirnay F, Lacroix M, Mosora F, Luyckx A, Lefebore R (1977) Effect of glucose ingestion on energy substrate utilization during prolonged muscular exercise. Eur J Appl Physiol 36: 247
Planz G, Planz R (1981) Dissociation between duration of plasma catecholamine and blood pressure responses to beta-adrenergic blockade in normotensive subjects during physical exercise. Europ Clin Pharmacol 14: 83
Pluoin PF, Comoy E, Bohuon C, Corvol P, Menard J (1979) Activité rénine et noradrénaline plasmatiques au cours du traitement antihypertenseur par l’acébutolol. Nouv Presse Med 8: 1905
Ponari O, Civardi E, Poti R (1972) Action of some betablockers on plasma fibrinolysis in vitro and in vivo in man. Arzneim Forsch 22: 629
Porte D, Williams Jr RH (1966) Inhibition of insulin release by norepinephrine in man. Science 152: 1248
Powers SP, Howley ET, Cox R (1982) A differential catecholamine response during prolonged exercise and passive heating. Med Sci Sports Exercise 14: 435
Prachar H, Heller G, Jobst Ch, Kiss E, Nobis H, Spiel R, Enenkel W (1976) Zum koronaren Risiko bei Hypertonikern. Herz/Kreis 18: 174
Prichard BNC (1964) Hypotensive action of pronethalol. Br Med J1: 1227
Pristantz H, Pavek P, Klein W (1977) Die Rolle der Serumtriglyceride als koronarer Risikofaktor. ZKardiol 66: 216
Pruett ED, Maehlum S (1973) Muscular exercise and metabolism in male juvenile diabetics. Energy metabolism during exercise. Scand J Clin Lab Invest 32: 139
Putzeys MR, Hoobler SW (1972) Comparison of Clonidin and methyldopa on blood pressure and side effects in hypertensive patients. Am Heart J 83: 464
Quabbe H-J (1969) Radioimmunologische Bestimmung von Wachstumshormon im Plasma des Menschen. Z Klin Chem Klin Biochem 7: 259
Quabbe H-J, Ramek W, Luyckx AS (1977) Growth hormone, glucagon and insulin response to depression of plasma free fatty acids and the effect of glucose infusion. J Clin Endocrinol Metab 44: 383–391
Raben MS, Hollenberg CH (1959) Effect of growth hormone on plasma fatty acids. J Clin Invest 38: 484
Rahn KH, Hawlina A, Kersting F, Planz G (1974) Studies on the antihypertensive action of the optical isomers of propranolol in man. Naunyn-Schmiedeberg’s Arch Pharmacol 286: 319
Raine HE, Pickering TG (1977) Cardiovascular and sympathetic response to exercise after long-term beta-adrenergic blockade. Brit Med J 2: 90
Ramdohr B, Biamino G, Schüren KP, Schröder R (1975) Dopamin bei der Behandlung der akuten schweren Herzinsuffizienz. Med Welt 26: 540
Rändle P, Garland PB, Hales NC (1963) The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1: 785
Rasmussen S, Rasmussen K (1979) Influence of metoprolol alone and in combination with a thiazid diuretic, on blood pressure, plasma volume, extracellular volume and glomerular filtration rate in essential hypertension. Eur J Clin Pharmacol 15: 305
Reindell H, König K, Roskamm H (1967) Funktionsdiagnostik des gesunden und kranken Herzens. Schattauer, Stuttgart
Reisin E, Abel R, Modan M, Silverberg DS, Eiahon HE, Modan B (1978) Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. New Engl Med 298: 1
Relman AS (1980) Mild hypertension: no more benign neglect. New Engl J Med 302: 293
Rennie MJ, Winder HW, Holloszy JO (1976) A sparing effect of increased plasma fatty acids on muscle and liver glycogen content in the exercising rat. Biochem J156: 647
Reuben SR (1981) Comparative effects if two antihypertensive drugs on blood pressure and heart rate response during ergometrie exercise. Abstract, Symposium, Potassium, The Heart and Hypertension. Rome
Reybrouck T, Amery A, Billiet L (1977) Hemodynamic response to graded exercise after chronic beta-adrenergic blockade. J Appl Physiol 42: 133
Rhoads GG, Guldbrandsen ChL, Kagan A (1976) Serum lipoproteins and coronary heart disease. New Engl J Med 294
Ricci DR, Orlick AE, Cipriano PR, Guthauer DF, Harrison DC (1979) Altered adrenergic activity in coronary arterial spasm: Insight into mechanism based in study of coronary hemodynamics and the electrocardiogramm. Am J Cardiol 43: 1073
Richter EA, Galbo H, Christensen NJ (1981) Control of exercise-induced muscular glycogenosis by adrenal medullary hormones in rats. J Appl Physiol 50: 21
Richter EA, Ruderman NB, Gavras H, Belur ER, Galbo H (1982) Muscle glycogenolysis during exercise: dual control by epinephrine and contractions. Am J Physiol 242: E 25
Rieckert H, Kattwinkel W, Riechelmann H, Kuß A, Sieran R (1981) Gefaßreaktionen der unteren Extremitäten auf eine akute Betablockade in Ruhe und bei körperlicher Belastung. Med Welt 24: 967
Rifkind BM, Tamir I, Heiss G, Wallace RB, Tyroler HA (1979) Distribution of high density and other lipoproteins in selected LRC, prevalence study populations: A brief survey. Lipids 14: 105
Rizza RA, Cryer PE, Gerich JE (1979) Role of glucagon, catecholamines and growth hormone in human glucose counter regulation. J Clin Invest 64: 62
Roberts WC (1975) The hypertensive diseases. Evidence that systemic hypertension is a greater risk factor to the development of other cardiovascular diseases than previously suspected. Amer J Med 59: 523
Robertson RP, Porte D (1973) Adrenergic modulation of basal insulin secretion in man. Diabetes 22: 1
Robertson SP, Kessich WGL (1979) The effect of PH on Ca+ + activated force in dog skeletal muscle fibres. Pfügers Arch 380: 41
Röcker L (1977) Der Einfluß körperlicher Aktivität auf das Blut. In: Hollmann W (Hrsg) Zentrale Themen der Sportmedizin. Springer, Berlin Heidelberg New York, S 91
Rost R, Hollmann W, Liesen H (1976) Körperliches Training mit Hochdruckpatienten, Ziele und Probleme. Herz/Kreisl 2: 680
Rost R (1979) Kreislaufreaktion und -adaptation unter körperlicher Belastung. Osang, Bonn
Rost R, Hollmann W (1982) Belastungsuntersuchungen in der Praxis. Thieme, Stuttgart
Rowlands DB, Irland MA, Stallard TJ, Glover TR, McLeay AB, Watson RDS, Littler WA (1982) Assessment of left ventricular mass and its response to antihypertensive treatment. Lancet II: 467
Roth J, Glick GM, Yalow RS, Berson SA (1963) Hypoglycaemia: a powerful stimulus to secretion of growth hormone. Science 140: 987
Sacca L, Sherwin R, Hendler R, Felig P (1976) Influence of continious physiologic hyperinsulinemia on glucose kinetics and counter-regulatory hormones in normal and diabetic humans. J Clin Invest 58: 7
Sahn DJ, de Maria A, Kisslo J, Weyman A (1977) The Committee on M-mode standardization of the American Society of Echocardiography. Recommendations regarding quantification in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58: 1072
Sannerstedt R, Julius S (1972) Systemic hemodynamics in borderline arterial hypertension: Response to static exercise before and under the influence of propranolol. Cardiovasc Res 6: 398
Sarnoff S, Case JRB, Stainsky WN, Macruz R (1958) Hemodynamic determinants of oxygen consumption of the heart with special reference to the tensiontime-index. Am J Physiol 192: 148
Schade DS, Woodside W, Eaton RP (1979) The role of glucagon in the regulation of plasma lipids. Metabolism 28: 874
Schalch DS, Kipnis DM (1965) Abnormalities in carbohydrate tolerance associated with elevated plasma nonesterified fatty acids. J Clin Invest 44: 2010
Schettler G (1979) Ist der Kampf gegen die Herz- und Gefäßkrankheiten zu gewinnen? Z Allg Med 55: 667
Schimert E (1965) Körperbelastung und Koronarerkrankungen. Münch Med Wschr 18: 894
Schnelle K, Schinz A, Klein G, Fenze E, Radespeck A (1978) Klinisch-pharmakologische Befunde zur Differentialtherapie mit Beta-Rezeptoren-Blockern. Autoreferateband 5. Herbsttagung Dtsch Ges Kreisl Forsch Z Kardiol Suppl 5: 70
Schoknecht G, Thefeld W, Hoffmeister H (1980) Bluthochdruck, Übergewicht und Hypercho- lesterinämie: unabhängige Faktoren? Med Welt 31: 588
Schönig A, Dietz R, Kaden F, Luth JB, Maurer W (1977) Sympathischer Gefaßtonus bei ß- Blockade. Autoreferate 43. Jahrestag Dtsch Ges für Kreislaufforschung, S. 12
Scholhamer C, Feiig P, Hendler R-G (1971) Propranolol hypoglycemia: increases peripheral effectiveness of insulin. Clin Res 19: 736
Schulte W (1980) Blutdruckreaktivität unter emotionalem Streß bei essentieller Hypertonie - pathologische und diagnostische Aspekte. In: Franz I-W (Hrsg) Belastungsblutdruck bei Hochdruckkranken. Springer, Berlin Heidelberg New York, S 59
Scow RQ, Chernick SS (1970) Mobilization, transport and utilization of free fatty acids. Comp Biocheml8: 19
Sen S, Tarazi RC, Khairallah PA, Bumpus FMM (1974) Cardiac hypertrophy in spontaneously hypertensive rats. Circ Res 35: 775
Sen S, Tarazi RC (1983) Regression of myocardial hypertrophy and influence of adrenergiv system. Amer J Physiol 13: 97
Scipel L, Breithardt G, Döhring HP (1977) Die Wirkung von Atenolol auf den Sinusknoten und die intrakardiale Erregungsleitung beim Menschen im Vergleich zu Propranolol. Z Kardiol 66: 719
Shaw J, England JD, Hua ASD (1978) Betablocker and plasma triglycerides. Br Med J1: 986
Shaw DB, Holman RR, Gowers JI (1980) Survival in sinoatrial disorder. Br Med J 1: 139
Shephard J, Packard J, Patsch R, Gotto jr AM, Taunton OD (1979) Effects of nicotinic acid therapy on plasma high density lipoprotein subfraction distribution and composition and on apolipoprotein metabolism. J Clin Invest 63: 858
Simon G, Dickhut HH, Windscheidt U, Kindermann W, Keul J (1979) Hämodynamische und metabolische Auswirkungen der Betarezeptorenblockade durch Metipranolol. Herz/ Kreisl 11: 134
Sivertson R, Andersson O, Hansson L (1979) Blood pressure reduction and vascular adaption. Acta Med Scand205: 477
Smith D, Odel H, Kernohan JW (1950) Causes of death in hypertension. Amer J Med 9: 516
Smith U (1983) Adrenergic control of lipid metabolism. Acta Med Scand (Suppl 672 ): 41
Smithen CS, Balcon R, Sowton E (1971) Use of his potentials to assess changes in atrioventricular conduction produced by a series of beta-adrenergic blocking agents. Br Heart J 33: 995
Sokolow M, Perloff D (1961) The prognosis of essential hypertension treated conservatively. Circulation 23: 697
Sokolow M, Perloff D, Cowan R (1982) A 10-year prospective study of the incidence of cardiovascular events in hypertensive patients utilizing ambulatory blood pressure measurements. Abstract, Ninth Scientific Meeting of the International Society of Hypertension, Mexico City
Soman VR (1979) Increased insulin binding to monozytes after physical training. New Engl J Med 301: 1200
Stamler J, Schoenberger JA, Schekelle RB, Stamler R (1974) Hypertension. The problem and the challenge. In: Merck, Sharp & Dohme The hypertension handbook. Merck & Co West Point, Pa 19486
Stamler JSt, Farinario E, Mojounier LM, Haie Y, Moss D, Stamler R (1980) Prevention and control of hypertension by nutritional-hygienic means. J Am Med Ass 18: 1819
Stankiewics-Chroszucha B, Gorski J (1978) Effect of decreased availability of substrates on intramuscular triglyceride utilization during exercise. Eur J Appl Physiol 40: 27
Stanton HC (1972) Selective metabolic and cardio-vascular betareceptor antagonism in the rat. Arch Int Pharmacodyn 196: 246
Stegemann J, Kenner T (1974) A theory on heart control by muscular metabolic receptors. Arch Kreisl-Forsch 64: 185
Steinbrunn W, Klappenberger L, Lichtlen PR (1981) Die Häufigkeit des plötzlichen Herztodes bei der koronaren Herzkrankheit. Schweiz Med Wschr 111: 1697
Stephens J A, Taylor A (1972) Fatigue of maintained voluntary muscle contraction in man. J Physiol (Lond) 220: 1
Stoker JB, Sreeharan N, Linden RJ, Barbour MP, Lorimer AR, Hillis WS, Lawrie TDV (1979) The effects of exercise in hypertension controlled with metoprolol or methyldopa. Clin Sci 57: 391s
Strauer BE (1979) Das Hochdruckherz. Springer, Berlin Heidelberg New York
Strauer BR, Mahmoud M, Bayer F, Bohn J, Motz M (1984) Reversal of left ventricular hypertrophy and improvement of cardiac function in man by nifedipine. Europ Heart J 5 (Suppl 7) 53
Strauss HC, Gilbert M, Svenson RH, Miller HC, Wallace AG (1976) Electrophysiological effects of propranolol on sinus node function in patients with sinus node dysfunction. Circulation 54: 452
Streja D, Mymin D (1978) Effect of propranolol on HDL-Cholesterol concentrations. Br Med J 2: 1495
Stull JT, Mayer SE (1971) Regulation of phosphorylase activation in skeletal muscle in vivo. J Biol Chem 246: 5716
Sturm A, Schuster P (1977) Rehabilitation bei Hypertonic. Dtsch Med Wschr 102: 1732
Svardsudd K, Berglund G, Tibblin G (1976) Morbidity and mortality in treated and untreated hypertension: results from the Goteborg 50-year-old men study. Drugs (Suppl) 1: 34
Svardsudd K, Tibblin G (1979) Mortality and morbidity during 13.5 years follow-up in relation to blood pressure. The study of men born in 1913. Acta Med Scand 205: 483
Swedberg K, Hjalmarson A, Holmberg S (1979) Effects of work and acute beta-receptor blockade on myocardial noradrenaline release in congestive cardiomyopathy. Clin Cardiol 2: 423
Tarazi RC, Dustan HP (1972) Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations. Am J Cardiol 29: 633
Tarazi RC, Cevi MN (1982) Cardiac response to increased afterload: state of the review. Hypertension 4 (Suppl 1 ) II: 8
Tarazi RC, Sen S, Fouad FM, Wicker R (1983) Regression of myocardial hypertrophy: conditions and sequelae of reversal in hypertensive heart disease. In: Alpert NR (ed) Perspectives in Cardiovascular Research, vol 7. Myocardial Hypertrophy and Failure. New York Raven Press, 637
Tarazi RC, Gifford R (1983) Left ventricular hypertrophy and hypertension. JAMA 250: 1319
Tanaka N, Sagaguchi S, Oshige K, Niimura T, Kanehsia T (1976) Effect of chronic administration of propranolol on lipoprotein composition. Metabolism 25: 1071
Taylor SH (1975) The circulation in hypertension. In: Burley DM, Birdwood GFB, Fryer JH, Taylor SH Hypertension - its nature and treatment. Metropolis press, London, p 29
Tesch P (1980) Muscle fatique in man with special reference to lactate accumulation during short term intense exercise. Acta Physiol Scand (Suppl): 480
Thadani U, Parker JO (1979) Propranolol in angina pectoris. Duration of inproved exercise tolerance and circulatory effects after acute oral administration. Am J Cardiol 44: 118
The Coronary Drug Project (1972) Findings leading to further modifications of its products with respect to dextrothyrotrine. J Amer Med Ass 220: 996
Tibblin G, Wilhelmsen L, Werko L (1975) Risk factors for myocardial infarction and death due to ischemic heart disease and other causes. Am J Cardiol 35: 514
Tomanek RJ (1982) Selective effects of a-methyldopa on myocardial cell components independent of cell size in normotensive and genetically hypertensive rats. Hypertension 4: 449
Toshima H, Koga Y, Yoshioka H (1975) Echocardiographic classification of hypertensive heart disease. A correlation study with clinical features. Jpn Heart J16: 377
Trap-Jensen J, Clausen JP, Noer J, Larsen CA, Krogsgaard AR, Christensen NJ (1976) The effect of beta-adrenoceptor blockers on cardiac output, liver blood flow and skeletal muscle blood flow in hypertensive patients. Acta Physiol Scand (Suppl) 440: 31
Trap-Jensen J, Clausen JP, Noer J, Krogsgaard AR (1979) Effects of long-term beta-receptor blockade with propranolol on splanchnic-hepatic blood-flow and substrate exchange at rest and during exercise in hypertensive patients. Scand J Clin Lab Invest 39: 27
Turner GG, Nelson RR, Nordstrom LA, Diefenthal HC, Gobel FL (1978) Comperative effect of nadolol and propranolol on exercise tolerance in patients with angina pectoris. Br Heart J12: 1361
Twentyman OP, Dislay A, Gribbin HR, Alberti KG, Tattersfield AE (1981) Effect of β-adrenergic blockade on respiratory and metabolic responses to exercise. J Appl Physiol 51: 788
United States Public Health Service Hospitals (1972) Morbidity and mortality in mild essential hypertension. Circulat Res, Suppl II 30 and 31: 110
Uusitupa M, Aro A & Pietikainen M (1980) Severe hypoglycaemia caused by physical strain and pindolol therapy. Annals of Clinical Research 12: 25–27
Vanhees L, Fagard R, Amery A (1981) Influence of endurance training in patients with ischemic heart disease treated with beta–adrenergic blocking agents. Abstract II. World Congress on Cardiac Rehabilitation. Jerusalem, p 101
Van Herwaarden CLA, Fennis JFM, Binkhorst A, van’t Laar A: Hemodynamic effects of adrenaline during treatment of hypertensive patients with propranolol and metoprolol. Eur J Clin Pharmacol 12: 397
Van Herwaarden CLA, Binkhorst RA, Fennis JFM, van’t Laar A (1979) Effects of propranolol and metoprolol on haemodynamic and respiratory indices and on percieved exertion during exercise in hypertensive patients. Br Heart J 41: 99
Van Zwieten PA, Timmermanns PB (1979) Comparisons between the acute hemodynamic effects and brain penetration of acebutolol and metoprolol. J Cardiovasc Pharmacol 1: 85
Vatner SF, Braunwald E (1975) Cardiovascular control mechanism in the conscious state. New Engl J Med 293: 970
Vaughan M, Steinberg D (1963) Effect of hormones on lipolysis and esteriflcation of free fatty acids during incubation of adipose tissue in vitro. J Lipid Res 4: 193
Vedin A, Wilhelmson C, Werkö L (1975) Chronic alprenolol treatment of patients with acute myocardial infarction after discharge from hospital. Acta Med Scand Suppl 575: 7
Vendsalu A (1960) Studies on adrenaline and noradrenaline in human plasma. Acta Physiol Scand (Suppl) 173, 49: 1
Vereinbarungen des Standardisierungskomitees für Ergometrie im ICSPE (1967) Leistungsumsatzbedingungen bei ergometrischen Untersuchungen. In: Mellerowicz H, Hansen G (Hrsg) 2. Internationales Seminar für Ergometrie, S. 314. Ergon, Berlin
Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effects of treatment on morbidity in hypertension: results in patients with diastolic blood pressure averaging 115 through 129 mmHg. J Am Med Ass 202: 1028
Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. II Results in patients with diastolic blood pressure averaging 90 through 114 mmHg. J Am Med Ass 213: 1143
Veterans Administration Cooperative Study Group on Antihypertensive Agents (1972) Effects of treatment on morbidity in hypertension. Ill Influence of age, diastolic pressure and prior- cardiovascular disease; further analysis of side effects. Circulation 45: 991
Veterans Administration Cooperative Study Group on Antihypertensive Agents (1975) Effects of treatment on morbidity in hypertension. Circulation 51: 1107
Vick RL, Todd EP, Luedke DW (1972) Exercise-induced hyperkalemia: Effect of adrenergic β-receptor antagonism. Cardiovasc Res Center Bull 10: 84
Viru A, Smirnova T, Tomson K, Matsin T (1979) Dynamics of blood levels of pituitary hormones during prolonged exercise. Abstract International Symposium Biochemistry on Exercise. Brüssel
Vizi F, Pagatsa S, Kaldor A (1965) On sympathetic regulation of carbohydrate metabolism in the liver. J Pharm Pharmacol 17: 805
Vranic M, Kawamori R, Pek S, Kovacevic N and Wrenshall GA (1976) The essentiality of insulin and the role of glucagon on regulating glucose utilization and production during strenuous exercise in dogs. J Clin Invest 57: 245–255
Waagstein F, Hjalmarson A, Varnauskas B, Wallentin I (1975) Effects of chronic beta-adrenergic receptor blockade in congestive cardiomyopathie. Br Heart J 37: 1022
Waal-Manning HJ (1976) Metabolic effects of beta-adrenoceptor blockers. Drugs (Suppl) 1: 121
Wahren J (1977) Glucose turnover during exercise in man. Ann NY Acad Sci 301: 45
Walter J, Kircher St, Dölle H, Dietz A (1977) Die Muskeldurchblutung unter Orciprenalin- Stimulation und Beta-Sympathikolyse mit Propranolol sowie Metoprolol. Herz/Kreisl 10: 576
Watson RDS, Stallard TJ, Littler WA (1979) Influence once-daily administration of β-adrenoceptor antagonists on arterial pressure and its variability. Lancet 6: 1210
Wang P, Clausen T (1976) Treatment of attacks in hyperkalaemic familial periodic paralysis by inhalation of salbutamol. Lancet 1: 221
Weber E, Gundert-Remy U, Schrey A (1977) Patienten Compliance. Witzstrock, Baden-Baden
Weidener J, Mellerowicz H (1970) Dosiertes Training bei hypertonen Kreislaufregulationsstörungen. Internist 287
Weidmann P, Glück Z (1979) Grenzwert-Hypertonie. Schweiz Med Wschr 109: 417
Williams P, Robinson D, Bailey A (1979) Highdensity lipoprotein and coronary risk factors in normal men. Lancet I: 72
William-Olsson T, Fellenius I, Smith U, Björntorp P (1979) Differences in metabolic responses to β-adrenergic stimulation after propranolol or metoprolol administration. Acta Med Scand 205: 201
Wilson PW, Garrison RJ, Castelli WP, Feinleib M, McNamara PM, Kannel WB (1980) Prevalence of coronary heart disease in the Framingham Offspring Study: Role of lipoprotein cholesterols. Amer J Cardiol 46: 649
Winder WW, Hagberg JM, Hickson RC, Ehsani AA and McLane JA (1979) Time course of sympathoadrenal adaptation to endurance exercise training in man. J Appl Physiol 45: 370–374
Winder WW, Hickson RC, Hagberg JM, Ehsani AA and McLane JA (1979) Training induced changes in hormonal metabolic responses to submaximal exercise. J Appl Physiol 46: 766–771
Winer N, Mason WD, Carter CH, Willonghby TL, Kochak GM, Cohen I, Bell S (1979) Effects of atenolol on blood pressure, heart rate, renin, and norepinephrine during exercise. Clin Pharmacol Ther26: 315
Wirth A, Neermann G, Eckert W, Henck CC and Weicker H (1979) Metabolic response to heavy physical exercise before and after a 3-month training period. Eur J Appl Physiol 41: 51
Wirtzfeld A, Klein G, Delius W, Sack D (1978) Behandlung des akuten Myokardinfarktes mit Metoprolol. Dtsch Med Wschr 103: 566
Wolff G (1978) Bluthochdruck - die Pest unserer Zeit. Moderne Medizin 2: 87
Wolfram G, Schlierf G (1979) LDL-Cholesterin und HDL-Cholesterin - Risikofaktor und Schutzfaktor? Internist 20: 613
Wong M, Shah PM, Taylor RD (1981) Reproducibility of left ventricular internal dimension with M-mode echocardiography: effects of heart size, body position and transducer angulation. Amer J Cardiol 47: 1068
World Health Organization (1959) Hypertension and coronary heart disease: classification and criteria for epidemological studies. Technical Report series No 168
World Health Organization (1962) Arterial hypertension and ischaemic heart disease. Technical Report series No 231
Yamaguchi N, De Champlain J, Nadeau RA (1977) Regulation of norepinephrine, release from cardiac sympathetic fibers in the dog by presynaptic alpha and beta receptors. Circ Res 41: 108–17
Yamori Y, Tarazi RC, Ooshima A (1980) Effect of betablockers on cardiovascular structural changes in spontaneous and induced hypertension. VII. Congress Internat Soc Hypertension, New Orleans, 13
Zerzawy R, Bachmann K, Fleischer H (1976) Telemetrische Untersuchungen der Herz- und Kreislaufbelastung auf einem Trimmpfad. Dtsch Med Wschr 17: 664
Zerzawy R, Reis A, Bachmann K (1977) Belastungshypertonie bei Hochdruckkranken und Grenzwerthypertonikern. Autoreferateband 43, Jahrestagung Dtsch Ges Kreislaufforsch 112
Zerzawy R (1980) Telemetrie von arteriellem Druck und Herzfrequenz unter alltäglichen und sportlichen Belastungen im Vergleich zur Fahrradergometrie. In: Franz I-W (Hrsg) Belastungsblutdruck bei Hochdruckkranken. Springer, Berlin Heidelberg New York, S161
Zierler KL (1976) Fatty acids as substrates for heart and skeletal muscle. Circ Res 38: 459
Zilker Th, Schnelle K, Klein G, Schniz A, Fenzl F, Radlspeck A, Bottermann P (1978) Kohlenhydrat- und Fettstoffwechselwirkungen von Alprenolol und Metoprolol unter betaadrenerger Stimulation mit Isoproterenol am Stoffwechselgesunden. Verh Dtsch Ges Inn Med 84: 1163
Zinman B, Murray FT, Vranic M, Albisser M, Leibel BS, McLean PA and Marliss EB (1979) Glucoregulation during moderate exercise. Diabetes 28, Suppl 1: 82
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Franz, IW. (1986). Literatur. In: β-Rezeptorenblocker in der Hochdrucktherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71340-8_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-71340-8_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-16708-2
Online ISBN: 978-3-642-71340-8
eBook Packages: Springer Book Archive